BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
HIV infection
,
Embryo
,
Personalized medicine
,
Aspirin
,
rs7903146
,
EGFR
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Aryl hydrocarbon receptor/Aryl hydrocarbon receptor repressor
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Lung
Skin
Stomach pyloric
Trachea
Esophagus
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Parvovirus infection
Bacterial infection due to Bacillus
Waardenburg's syndrome
Viremia
Disease due to Enterovirus
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Adenylate Cyclase Toxin
Thrombopoietin
flt3 ligand protein
2,4-diaminoquinazoline
fragment C, human serum albumin
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
LINC00888
C2orf71
TYMS
NOP2
MEIS2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Splenic B cells deficent in NFATc1 in response to stimulation with antil-IgM
Imatinib response in spleenocytes
Response of neural stem cells with JMJD3 knockdown to TGFbeta1 treatment
B-cells BCR-stimulated in TAK1 KO and and WT mice: a time course
Pre-B cells transformed with BCR-ABL1, overexpressing BACH2, and harboring BCL6 knockout
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Aryl hydrocarbon receptor/Aryl hydrocarbon receptor repressor
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Deficient T Regulatory Cell (Treg) Function in Patients With Relapsing Remitting Multiple Sclerosis
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ